Science Explorer Back to mapMap
Discussion
Company · Lexington · United States

Naprogenix (United States)

naprogenix.comROR OpenAlex
Research works
7
▼ 45% vs 2018-21
Citations
316
43.6 per fractional work
Top-10% rate
0.0%
all institutions 10.0%
Open access
66%
world 40%
Naprogenix (United States)

Not ranked overall: Naprogenix (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Naprogenix (United States) work in?

In all years, 70% of research at Naprogenix (United States) is in Life Sciences, 16% in Physical Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (59%), Medicine (14%), Materials Science (10%). It does 2.0× the world's share of Life Sciences.

Life Sciences: 5 fractional works · 69.7% of its workBiochemistry, Genetics and Molecular Biology: 4 fractional works · 59.4% of its workMolecular Biology: 3 fractional works · 42.4% of its workBiotechnology: 1 fractional works · 14.6% of its workCell Biology: 0 fractional works · 2.3% of its workAgricultural and Biological Sciences: 0 fractional works · 5.0% of its workPlant Science: 0 fractional works · 3.9% of its workInsect Science: 0 fractional works · 1.1% of its workNeuroscience: 0 fractional works · 3.0% of its workCellular and Molecular Neuroscience: 0 fractional works · 1.5% of its workSensory Systems: 0 fractional works · 1.5% of its workImmunology and Microbiology: 0 fractional works · 2.3% of its workImmunology: 0 fractional works · 2.3% of its workPhysical Sciences: 1 fractional works · 16.1% of its workMaterials Science: 1 fractional works · 9.9% of its workMaterials Chemistry: 1 fractional works · 9.9% of its workChemistry: 0 fractional works · 2.3% of its workSpectroscopy: 0 fractional works · 2.3% of its workEngineering: 0 fractional works · 2.3% of its workBiomedical Engineering: 0 fractional works · 2.3% of its workEnvironmental Science: 0 fractional works · 1.5% of its workIndustrial and Manufacturing Engineering: 0 fractional works · 1.5% of its workHealth Sciences: 1 fractional works · 14.2% of its workMedicine: 1 fractional works · 14.2% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 4.5% of its workPharmacology: 0 fractional works · 2.6% of its workComplementary and alternative medicine: 0 fractional works · 2.3% of its workNeurology: 0 fractional works · 2.3% of its workOncology: 0 fractional works · 2.3% of its workALL ITS WORKNaprogenix(United States)7fractional works, all years
Life Sciences70%Physical Sciences16%Health Sciences14%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 9 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology459.4%
    2. Agricultural and Biological Sciences05.0%
    3. Neuroscience03.0%
    4. Immunology and Microbiology02.3%
    1. Materials Science19.9%
    2. Chemistry02.3%
    3. Engineering02.3%
    4. Environmental Science01.5%
    1. Medicine114.2%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

What are the most cited papers from Naprogenix (United States)?

The most cited paper from Naprogenix (United States) is "The Transcription Factor CrWRKY1 Positively Regulates the Terpenoid Indole Alkaloid Biosynthesis in Catharanthus roseus" (Nitima Suttipanta, Sitakanta Pattanaik, Mukul Kulshrestha et al., 2011), with 441 citations. Next come "Adsorption and Recovery of Polyphenolic Flavonoids Using TiO2-Functionalized Mesoporous Silica Nanoparticles" (75) and "Nanoharvesting of bioactive materials from living plant cultures using engineered silica nanoparticles" (30).

Most cited papers
#PaperReleasedCitations
1 The Transcription Factor CrWRKY1 Positively Regulates the Terpenoid Indole Alkaloid Biosynthesis in Catharanthus roseus Nitima Suttipanta, Sitakanta Pattanaik, Mukul Kulshrestha et al. · PLANT PHYSIOLOGY Open access 11 Oct 2011 441
2 Adsorption and Recovery of Polyphenolic Flavonoids Using TiO2-Functionalized Mesoporous Silica Nanoparticles M. Arif Khan, William T. Wallace, Syed Z. Islam et al. · ACS Applied Materials & Interfaces Open access 21 Aug 2017 75
3 Nanoharvesting of bioactive materials from living plant cultures using engineered silica nanoparticles M. Arif Khan, William T. Wallace, Jatinder Sambi et al. · Materials Science and Engineering C Open access 11 Sep 2019 30
4 A nicotinic receptor-mediated anti-inflammatory effect of the flavonoid rhamnetin in BV2 microglia Joseph A. Lutz, Mukul Kulshrestha, Dennis Trent Rogers et al. · Fitoterapia Open access 25 Jun 2014 27
5 Novel multifunctional pharmacology of lobinaline, the major alkaloid from Lobelia cardinalis Dustin Brown, Dennis Trent Rogers, François Pomerleau et al. · Fitoterapia Open access 30 Apr 2016 19
All 19 most cited papers, with filters and sorting

Which research topics does Naprogenix (United States) publish most on?

By volume in 2022-now: Ginkgo biloba and Cashew Applications, Biochemical and biochemical processes, Parkinson's Disease Mechanisms and Treatments and Peptidase Inhibition and Analysis.

Ginkgo biloba and Cashew Applications: 0 fractional worksBiochemical and biochemical processes: 0 fractional worksParkinson's Disease Mechanisms and Treatments: 0 fractional worksPeptidase Inhibition and Analysis: 0 fractional worksAdvanced biosensing and bioanalysis techniques: 0 fractional worksChemical Synthesis and Analysis: 0 fractional works
Complementary and alternative medicineBiotechnologyNeurologyOncology1 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Ginkgo biloba and Cashew Applications Complementary and alternative medicine 0 works
  2. 2 Biochemical and biochemical processes Biotechnology 0 works
  3. 3 Parkinson's Disease Mechanisms and Treatments Neurology 0 works
  4. 4 Peptidase Inhibition and Analysis Oncology 0 works
  5. 5 Advanced biosensing and bioanalysis techniques Molecular Biology 0 works
  6. 6 Chemical Synthesis and Analysis Molecular Biology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available65.5%not open34.5%

World: 40% of research is openly available.

How has Naprogenix (United States)'s research output changed?

Output in 2022-2025 was 45% lower than in 2018-2021.

201020152020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Naprogenix (United States) as a percentage of every work published that year, 0.0000096% in 2022.

0.000020%0.000040%Naprogenix (United States)0.0000090% in 202420102020

Fractional works of Naprogenix (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Lexington

All research institutions in Lexington

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Naprogenix (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.